Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The Jacobs Foundation Announces the Recipients of the Klaus J. Jacobs Awards, Endowed with 1.2 Million Swiss francs (780.000 GBP)


News provided by

Jacobs Foundation

10 Oct, 2014, 07:00 GMT

Share this article

Share toX

Share this article

Share toX

ZURICH, October 10, 2014 /PRNewswire/ --

On today's WHO World Mental Health Day, the Jacobs Foundation, an international Zurich-based foundation supporting child and youth development, announces the recipients of this year's Klaus J. Jacobs Awards. The Research Prize, endowed with 1 million Swiss francs (about 650.000 GBP), goes to Michael Meaney. The Best Practice Prize, which includes an award of 200,000 Swiss francs, goes to the trauma intervention program SHARPZ in Zambia. The Klaus J. Jacobs Awards will be presented on December 5, 2014 at the University of Zurich.

Michael Meaney - 2014 Klaus J. Jacobs Research Prize Laureate  

Michael Meaney, a McGill University professor and a senior fellow of the Canadian Institute for Advanced Research, is awarded the 2014 Klaus J. Jacobs Research Prize in recognition of his ground-breaking achievements in child and youth development. A jury of experts selected Meaney for this honour because of his "pioneering, cutting edge research on the biological mechanisms by which parental behaviour affects offspring development. Beyond the purely scientific value of his research, Meaney's work has tangible implications for psychosocial interventions and social policy measures to promote child and youth development."

Meaney studies how experiences shape biology at the molecular level. His research focuses on the following questions: How do genes and environment interact to produce individual differences in brain function? Why are some better able than others to deal with illness, psychological problems or adverse life circumstances? Is it possible to determine an individual's susceptibility to certain environmental influences by looking at that person's biology, and can interventions reduce or even eliminate that susceptibility?

Life experiences alter genes
In the 1990s, using studies of mother rats and their pups, Meaney was able to identify biological mechanisms by which a mother's care for her young - that is, her behaviour, rather than her genes - can result in a long-term change in the offspring's development.
In 2009, Meaney and his colleagues applied these insights to human studies. They looked at samples of brain tissue from suicide victims who had been abused as children, suicide victims who had not been abused, and individuals who had not been abused and had died of natural causes.

For the first time, it was possible to show for humans that childhood experiences leave biochemical markers in an individual's DNA. Experiences in the family context, particularly during the first years of life, become part of a child's biology and influence the child's health and attainments throughout life - in positive as well as negative ways.

"One size doesn't fit all"-The future of intervention lies in customization
"Our biggest challenge now is to understand the biology of vulnerability, the risk an individual carries," explains Meaney. "Second, can we then chart the reversibility through intervention programs? And can we evaluate the biological impact of the intervention at the level of the individual?"

Meaney's research has the potential to produce significant changes in social policy. Now that we know that childhood experiences change how genes are expressed, we may be able to identify the children who are most at risk and put in place appropriate interventions. This will make it possible to develop therapies tailored to the needs of each child - therapies that are likely to produce the greatest benefits and to be most cost-effective over the long term.

Serenity Harm Reduction Programme Zambia -
2014 Klaus J. Jacobs Best Practice Prize Laureate 

Zambia is one of the African countries that are most badly affected by the HIV/Aids pandemic. Almost 8 percent of today's population (approximately 1.1 million people) is HIV-infected. This led to the aggravation of poverty and other consequences many of the young people and their families are trapped in. Not uncommonly the use of alcohol or drugs is a means of coping with social and economic stress.

The Serenity Harm Reduction Programme Zambia (SHARPZ) is a collaborative agency offering comprehensive alcohol- and drug-abuse prevention services as well as targeted programs to promote mental health and prevent harmful substance use. SHARPZ takes a public-health approach to the issue of drug and alcohol abuse, influenced by the social and medical realities of the response to the HIV/AIDS pandemic. It has developed evidence-based interventions designed to address not just the issues that arise from substance abuse, but the factors that contribute to it, such as childhood trauma.

SHARPZ has used Trauma-Focused Cognitive Behavioural Therapy (TF-CBT) as an evidence-based approach to address the needs of children who have been affected by trauma and their families. "SHARPZ is not only an active participant in many of the studies of TF-CBT that have been conducted in Zambia; it is also the one organization that has continued to provide counsellors trained in TF-CBT and ongoing supervision, and that offers these services to the community on a regular basis", explains Dr. Mark van Ommeren, Mental Health Expert of the World Health Organisation.  

"This is an exceptional achievement that is extremely rare in low-resource countries - the art of sustaining an evidence-based intervention," according to a statement by the Jacobs Foundation Board of Trustees. "SHARPZ has been chosen to receive the 2014 Klaus J. Jacobs Best Practice Prize in recognition of its leadership in implementing evidence-based best practices to help traumatized children in a low-resource, high-stress population."

The Jacobs Foundation
The Jacobs Foundation was established by Klaus J. Jacobs and his family in 1989 in Zurich, Switzerland. In 2001, the founder surrendered his entire share of the Jacobs Holding AG to the Jacobs Foundation. The Foundation's endowment in 2013 totalled 4.5 billion Swiss francs ($4.8 billion). The Jacobs Foundation's goal is to contribute to productive youth development by supporting research and intervention projects and through dialogue and network building. The Jacobs Foundation is one of the leading European foundations in the space of child and youth development. The Foundation's grant making totalled Swiss francs 40.1M in 2013. Annual report 2013. About two-thirds of the grantmaking goes to scientific research in youth and child development. 

Media contact:
Cathrin Gutwald
cathrin.gutwald@jacobsfoundation.org
T +41(0)44-388-61-26
M +41(0)79-9167003
http://www.jacobsfoundation.org    

Note for the Media:
The entire Press release, additional
information and images are available at
http://jacobsfoundation.org/what-we-do/klaus-j-jacobs-awards/media-kit/

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.